LegiList
Congress, Made Clear.
Home
My LegiList
Browse
Legislators
Bills
Laws
Committees
Campaign Finance
Analytics
Weekly Briefing
Support LegiList
For past Congresses, use the Browse menu.
HR 3536
115th Congress • 2017–2019 (Ended)
To require persons who undertake Federally funded research and development of drugs to enter into reasonable pricing agreements with the Secretary of Health and Human Services.
Full Bill Page
Lobbying Summary
Organizations below reported lobbying activity on this bill. Expand to view filing details.
Loading filings…